News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
Presentation TCT 2022 TCT 4: Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation Presenter: Johny Nicolas September 17, 2022
Presentation TCT 2022 TCT 2: Two-Year Outcomes in High Bleeding Risk Patients with Bifurcations after Percutaneous Coronary Intervention and One Month Dual Antiplatelet Therapy Presenter: Ajay Kirtane September 17, 2022
Presentation TCT 2022 TCT 15: Dual antiplatelet therapy-based de-escalation in acute coronary syndrome: An individual patient data meta-analysis Presenter: Jeehoon Kang September 17, 2022
Presentation TCT 2022 TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry. Presenter: Giulia Masiero September 17, 2022
Presentation TCT 2022 TCT 21: Preferred Strategy in the Era of Short-Term Dual Antiplatelet Therapy: A Systematic Review and Network Meta-Analysis of Randomized Trials Presenter: Toshiki Kuno September 17, 2022
News Conference News TCT 2021 Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes Yael L. Maxwell November 09, 2021
News Conference News TCT 2021 Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets Caitlin E. Cox November 06, 2021
News Conference News TCT 2021 Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter? Todd Neale November 06, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Conference News TCT 2021 PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
News Conference News TCT 2021 OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III Shelley Wood November 04, 2021
News Conference News TCT 2021 ‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients Yael L. Maxwell November 04, 2021
News Conference News TCT 2021 FAVOR III China Adds Strength to Value of QFR-Guided PCI L.A. McKeown November 04, 2021
News Conference News TCT 2021 De-escalating Prasugrel Reduces Net Events in Complex PCI for ACS Yael L. Maxwell October 22, 2021
News Conference News TCT 2020 Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk Caitlin E. Cox October 15, 2020
News Conference News TCT 2020 Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI Todd Neale October 14, 2020
Presentation TCT 2020 TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease Presenter: Markus Krackhardt October 14, 2020
Presentation TCT 2020 TCT 062: Short Term Dual Anti-Platelet Therapy Followed by P2Y12 Monotherapy After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Control Trials Presenter: Mohammad Saud Khan October 14, 2020